Floatz logo

Therapeutic Asset Ratings

128 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
cd22 car-t
Follicular Lymphoma
Stanford UniversityP1C (37)
cd79b-19 car t cells
Follicular Lymphoma
Marcela V. Maus, M.D.,Ph.D.P1C (37)
Docirbrutinib
Follicular Lymphoma
Carna Biosciences, Inc.P1C (37)
Hmpl-760
Follicular Lymphoma
HutchmedP1C (37)
iks03
Follicular Lymphoma
Iksuda Therapeutics Ltd.P1C (37)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Follicular Lymphoma
OncoNano Medicine, Inc.P1C (37)
Jwcar239
Follicular Lymphoma
Peking University Cancer Hospital & InstituteP1C (37)
lp-168
Follicular Lymphoma
Newave Pharmaceutical IncP1C (37)
lv20.19 car t cells
Follicular Lymphoma
Medical College of WisconsinP1C (37)
ly4584180
Follicular Lymphoma
Eli Lilly and CompanyP1C (37)
Neovax
Follicular Lymphoma
Dana-Farber Cancer InstituteP1C (37)
Onm-501
Follicular Lymphoma
OncoNano Medicine, Inc.P1C (37)
PRT1419
Follicular Lymphoma
Prelude TherapeuticsP1C (37)
psb202
Follicular Lymphoma
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)P1C (37)
Sgr-1505
Follicular Lymphoma
Schrödinger, Inc.P1C (37)
Stk-009
Follicular Lymphoma
SynthekineP1C (37)
Syncar-001
Follicular Lymphoma
SynthekineP1C (37)
Synkir-310
Follicular Lymphoma
Verismo TherapeuticsP1C (37)
Allogeneic Natural Killer Cells
Follicular Lymphoma
Paolo Caimi, MDP1C (35)
ft596
Follicular Lymphoma
Fate TherapeuticsP1C (35)
64Cu-LLP2A
Follicular Lymphoma
Washington University School of MedicineEarly P1C (34)
rd14-01
Follicular Lymphoma
He HuangEarly P1C (34)
rd14-01 cell
Follicular Lymphoma
He HuangEarly P1C (34)
Magrolimab
Follicular Lymphoma
National Cancer Institute (NCI)P1D (30)
Gadobutrol
Follicular Lymphoma
University Hospital, BonnD (28)
Showing 101 to 125 of 128 assets
PreviousPage 5 of 6Next